SLC6A8 and colorectal carcinoma: Direct inhibition of the FAK signaling pathway with PF‐562271 also led to decreased SLC6A8 expression in CRC cells (Figure 5G), and this effect persisted even when rhVTN was supplemented, provided that FAK phosphorylation was inhibited (Figure 5H).